452 related articles for article (PubMed ID: 3552595)
1. Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.
Clissold SP; Todd PA; Campoli-Richards DM
Drugs; 1987 Mar; 33(3):183-241. PubMed ID: 3552595
[TBL] [Abstract][Full Text] [Related]
2. Imipenem/cilastatin: the first carbapenem antibiotic.
Lyon JA
Drug Intell Clin Pharm; 1985 Dec; 19(12):895-9. PubMed ID: 3910385
[TBL] [Abstract][Full Text] [Related]
3. Thienamycin: development of imipenen-cilastatin.
Kahan FM; Kropp H; Sundelof JG; Birnbaum J
J Antimicrob Chemother; 1983 Dec; 12 Suppl D():1-35. PubMed ID: 6365872
[TBL] [Abstract][Full Text] [Related]
4. Imipenem-cilastatin sodium, a broad-spectrum carbapenem antibiotic combination.
Pastel DA
Clin Pharm; 1986 Sep; 5(9):719-36. PubMed ID: 3530614
[TBL] [Abstract][Full Text] [Related]
5. Carbapenems, a new class of beta-lactam antibiotics. Discovery and development of imipenem/cilastatin.
Birnbaum J; Kahan FM; Kropp H; MacDonald JS
Am J Med; 1985 Jun; 78(6A):3-21. PubMed ID: 3859213
[TBL] [Abstract][Full Text] [Related]
6. [Imipenem/cilastatin: in vitro activity, concentrations in plasma and prostatic adenoma and therapeutic results in patients with complicated urinary tract infections].
Naber KG; Adam D; Bauernfeind A; Hönig E
Infection; 1986; 14 Suppl 2():S122-9. PubMed ID: 2428754
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic profile of imipenem/cilastatin in normal volunteers.
Drusano GL; Standiford HC
Am J Med; 1985 Jun; 78(6A):47-53. PubMed ID: 3859215
[TBL] [Abstract][Full Text] [Related]
8. Combined imipenem/cilastatin and tobramycin therapy of multiresistant Pseudomonas aeruginosa in cystic fibrosis.
Pedersen SS; Pressler T; Jensen T; Rosdahl VT; Bentzon MW; Høiby N; Koch C
J Antimicrob Chemother; 1987 Jan; 19(1):101-7. PubMed ID: 3104273
[TBL] [Abstract][Full Text] [Related]
9. Imipenem/cilastatin.
Barza M
Eur J Clin Microbiol; 1984 Oct; 3(5):453-5. PubMed ID: 6594233
[No Abstract] [Full Text] [Related]
10. [Fundamental and clinical studies on imipenem/cilastatin sodium in the field of pediatrics].
Nakashima T; Nakashima S; Hayakawa F; Miyachi Y; Hakamada S; Kuno K
Jpn J Antibiot; 1986 Jul; 39(7):1828-46. PubMed ID: 3464781
[TBL] [Abstract][Full Text] [Related]
11. Imipenem-cilastatin: the first thienamycin antibiotic.
Jacobs RF
Pediatr Infect Dis; 1986; 5(4):444-8. PubMed ID: 3523460
[No Abstract] [Full Text] [Related]
12. Pharmacokinetics of imipenem and cilastatin in volunteers.
Rogers JD; Meisinger MA; Ferber F; Calandra GB; Demetriades JL; Bland JA
Rev Infect Dis; 1985; 7 Suppl 3():S435-46. PubMed ID: 3863219
[TBL] [Abstract][Full Text] [Related]
13. Imipenem/cilastatin. A reappraisal of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.
Buckley MM; Brogden RN; Barradell LB; Goa KL
Drugs; 1992 Sep; 44(3):408-44. PubMed ID: 1382937
[TBL] [Abstract][Full Text] [Related]
14. [New antimicrobial agent series XXV: imipenem/cilastatin sodium].
Mashimo K
Jpn J Antibiot; 1987 Oct; 40(10):1713-23. PubMed ID: 3327961
[No Abstract] [Full Text] [Related]
15. [Use of imipenem-cilastatin in neonatal septicemias caused by gram-negative bacilli multiresistant to beta-lactam antibiotics].
Bompard Y; Lambert T; Gantzer A; Chastel A; Voinnesson A; Aufrant C
Pathol Biol (Paris); 1988 May; 36(5):521-4. PubMed ID: 3043351
[TBL] [Abstract][Full Text] [Related]
16. A multiclinic randomized study of the comparative efficacy, safety and tolerance of imipenem/cilastatin and moxalactam.
Calandra GB; Hesney M; Grad C
Eur J Clin Microbiol; 1984 Oct; 3(5):478-87. PubMed ID: 6389126
[TBL] [Abstract][Full Text] [Related]
17. [Pharmacokinetic and clinical studies with imipenem/cilastatin sodium in the pediatric field. Pediatric Study Group for Imipenem/Cilastatin Sodium].
Fujii R; Meguro H; Arimasu O; Yoshioka H; Fujita K; Maruyama S; Inyaku F; Nagamatsu I; Wagatsuma Y; Takase A
Jpn J Antibiot; 1986 Jul; 39(7):1912-37. PubMed ID: 3464785
[TBL] [Abstract][Full Text] [Related]
18. Comparative clinical trial of imipenem-cilastatin (N-formimidoyl-thienamycin-dehydropeptidase inhibitor) and cefazolin.
Marier RL; McCloskey RV; Dickenson G; Sanders CV; Aldridge KE; Hoffman T; Gutterman D; Janney A
J Antimicrob Chemother; 1983 Dec; 12 Suppl D():133-9. PubMed ID: 6365873
[TBL] [Abstract][Full Text] [Related]
19. Successful treatment of gram-negative bacillary meningitis with imipenem/cilastatin.
Rodriguez K; Dickinson GM; Greenman RL
South Med J; 1985 Jun; 78(6):731-2. PubMed ID: 3859018
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of imipenem and cilastatin in patients with cystic fibrosis.
Reed MD; Stern RC; O'Brien CA; Yamashita TS; Myers CM; Blumer JL
Antimicrob Agents Chemother; 1985 Apr; 27(4):583-8. PubMed ID: 3859245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
